Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Lara Tramontan"'
Autor:
Alessandro Guazzo, Enrico Longato, Mario Luca Morieri, Giovanni Sparacino, Bruno Franco-Novelletto, Maurizio Cancian, Massimo Fusello, Lara Tramontan, Alessandro Battaggia, Angelo Avogaro, Gian Paolo Fadini, Barbara Di Camillo
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Predicting the risk of cardiovascular complications, in particular heart failure hospitalisation (HHF), can improve the management of type 2 diabetes (T2D). Most predictive models proposed so far rely on clinical data not available at the hi
Externí odkaz:
https://doaj.org/article/1c8a53bef208449a9bb23ea74d0375c8
Autor:
Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Paolo Fadini
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Aim We aimed to compare cardiovascular outcomes of patients with type 2 diabetes (T2D) who initiated GLP-1 receptor agonists (GLP-1RA) or basal insulin (BI) under routine care. Methods We accessed the administrative claims database of the Ve
Externí odkaz:
https://doaj.org/article/447b44f87db0441db24a3ed1de63dab6
Autor:
Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Paolo Fadini
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-12 (2020)
Abstract Background Cardiovascular outcome trials in high-risk patients showed that some GLP-1 receptor agonists (GLP-1RA), but not dipeptidyl-peptidase-4 inhibitors (DPP-4i), can prevent cardiovascular events in type 2 diabetes (T2D). Since no trial
Externí odkaz:
https://doaj.org/article/c76f7e5a0ad54b6092e7c3c7c8f6108a
Autor:
Carlo Giaquinto, Giovanni Gabutti, Vincenzo Baldo, Marco Villa, Lara Tramontan, Nadia Raccanello, Francesca Russo, Chiara Poma, Antonio Scamarcia, Luigi Cantarutti, Rebecca Lundin, Emilia Perinetti, Xavier Cornen, Stéphane Thomas, Céline Ballandras, Audrey Souverain, Susanne Hartwig
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Monovalent varicella vaccines have been available in the Veneto Region of Italy since 2004. In 2006, a single vaccine dose was added to the immunisation calendar for children aged 14 months. ProQuad®, a quadrivalent measles-mumps
Externí odkaz:
https://doaj.org/article/31250fd2c55347ffb019b1efc6ecfcb9
Autor:
Giuseppe Roberto, Ingrid Leal, Naveed Sattar, A Katrina Loomis, Paul Avillach, Peter Egger, Rients van Wijngaarden, David Ansell, Sulev Reisberg, Mari-Liis Tammesoo, Helene Alavere, Alessandro Pasqua, Lars Pedersen, James Cunningham, Lara Tramontan, Miguel A Mayer, Ron Herings, Preciosa Coloma, Francesco Lapi, Miriam Sturkenboom, Johan van der Lei, Martijn J Schuemie, Peter Rijnbeek, Rosa Gini
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160648 (2016)
Due to the heterogeneity of existing European sources of observational healthcare data, data source-tailored choices are needed to execute multi-data source, multi-national epidemiological studies. This makes transparent documentation paramount. In t
Externí odkaz:
https://doaj.org/article/d394cafa299f4634a40b26cad8d6049b
Autor:
Barbara Di Camillo, Gian Paolo Fadini, Lara Tramontan, Angelo Avogaro, Giovanni Sparacino, Enrico Longato
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Cardiovascular Diabetology
Cardiovascular Diabetology
Aim We aimed to compare cardiovascular outcomes of patients with type 2 diabetes (T2D) who initiated GLP-1 receptor agonists (GLP-1RA) or basal insulin (BI) under routine care. Methods We accessed the administrative claims database of the Veneto Regi
Autor:
Giorgia Danieli, Caitlin Dodd, Consuelo Huerta-Alvarez, Vincent Bauchau, Klara Berencsi, Chris McGee, Tom De Smedt, Talita Duarte-Salles, Lara Tramontan, Ana Correa, Daniel Weibel, Hanne-Dorthe Emborg, François Haguinet, Gino Picelli, Kaatje Bollaerts, Olivia Mahaux, Lina Titievsky, Elisa Martín-Merino, Miriam C. J. M. Sturkenboom
Publikováno v:
Vaccine, 38, B38-B46. Elsevier
Weibel, D, Dodd, C, Mahaux, O, Haguinet, F, De Smedt, T, Duarte-Salles, T, Picelli, G, Tramontan, L, Danieli, G, Correa, A, McGee, C, Martín-Merino, E, Huerta-Alvarez, C, Berencsi, K, Emborg, H D, Bollaerts, K, Bauchau, V, Titievsky, L & Sturkenboom, M 2020, ' ADVANCE system testing : Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination ', Vaccine, vol. 38, pp. B38-B46 . https://doi.org/10.1016/j.vaccine.2019.06.040
Weibel, D, Dodd, C, Mahaux, O, Haguinet, F, De Smedt, T, Duarte-Salles, T, Picelli, G, Tramontan, L, Danieli, G, Correa, A, McGee, C, Martín-Merino, E, Huerta-Alvarez, C, Berencsi, K, Emborg, H D, Bollaerts, K, Bauchau, V, Titievsky, L & Sturkenboom, M 2020, ' ADVANCE system testing : Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination ', Vaccine, vol. 38, pp. B38-B46 . https://doi.org/10.1016/j.vaccine.2019.06.040
Introduction: The Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE) public-private collaboration, aimed to develop and test a system for rapid benefit-risk monitoring of vaccines using healthcare databases in Europe. T
Autor:
Hanne-Dorthe Emborg, Vincent Bauchau, Elisa Martín-Merino, Miriam C. J. M. Sturkenboom, Lara Tramontan, Kaatje Bollaerts, Daniel Weibel, Talita Duarte-Salles, Consuelo Huerta, Tom De Smedt, Gino Picelli, Edouard Ledent, Giorgia Danieli
Publikováno v:
Vaccine, 38, B65-B75. Elsevier
Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public-private collaboration aiming to develop and test a system for rapid benefit-risk (B/R) monitoring of vaccines using electronic health record
Autor:
Lara Tramontan, Giovanni Sparacino, Angelo Avogaro, Gian Paolo Fadini, Enrico Longato, Barbara Di Camillo
Publikováno v:
European Journal of Preventive Cardiology. 28:22-29
Aims Glucagon like peptide-1 (GLP-1) receptor agonists (GLP-1RA) are effective to control type 2 diabetes (T2Ds) and can protect from adverse cardiovascular outcomes. GLP-1RA are based on the human GLP-1 or the exendin-4 sequence. We compared cardiov
Autor:
Lara Tramontan, Gian Paolo Fadini, Roberto Vettor, Mario Luca Morieri, Andrea Vianello, Enrico Longato, Giovanni Sparacino, Giacomo Voltan, Daniele Falaguasta, Barbara Di Camillo, Silvia Tresso, Anna Maria Cattelan, Silvia Pinelli, Giorgia Costantini, Angelo Avogaro, Paola Fioretto, Elisa Selmin, Benedetta Maria Bonora
Publikováno v:
Diabetes, Obesity and Metabolism
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism
Because other coronaviruses enter the cells by binding to dipeptidyl-peptidase-4 (DPP-4), it has been speculated that DPP-4 inhibitors (DPP-4is) may exert an activity against severe acute respiratory syndrome coronavirus 2. In the absence of clinical